Optic Nerve Glioma
📧 Sign up to get email alerts when something new happens for Optic Nerve Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Update on the ProTRAIT proton therapy research infrastructure in neuro-oncology, with ongoing recruitment for several brain tumor conditions…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Modified CV Regimen in Optic Pathway Glioma [Phase 2]
Phase 2 clinical trial evaluating a modified CV regimen for optic pathway glioma in pediatric patients; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours [Phase 1, Phase 2]
Phase 1/2 trial data on intermittent dosing of selumetinib in children with Neurofibromatosis Type 1-related tumours, including plexiform ne…
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma [Phase 2]
Phase 2 trial update for selumetinib in Neurofibromatosis Type 1 with cutaneous neurofibromas; study completed with results posted in late 2…
-
CLINICAL_TRIALS withdrawal · 2017-07-26Clinical Trial Update: Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma [Phase 3]
A Phase 3 clinical trial comparing ANP Therapy with temozolomide for optic pathway glioma has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-02-20Clinical Trial Update: Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas [EARLY_Phase 1]
Early-phase trial evaluating autologous stem cell collection and reinfusion in newly diagnosed high-grade gliomas has been withdrawn.